Anna Santoro | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Book of Award

Dr. Anna Santoro | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Beth Israel Deaconess Medical Center | United States

Dr. Anna Santoro’s research profile reflects a strong and sustained contribution to biomedical and toxicological sciences, with a particular focus on inflammatory pathways, metabolic regulation, environmental toxicants, and neuroendocrine mechanisms. Her scholarly output comprises 28 peer-reviewed documents, which together have received 1,584 citations across 1,472 citing documents, demonstrating broad international impact and cross-disciplinary relevance. With an h-index of 22, her work shows both productivity and consistent citation performance. Key investigations explore the biological effects of non-dioxin-like polychlorinated biphenyls on cellular apoptosis, lipid metabolism, and endocrine signaling, alongside influential studies on palmitoylethanolamide and its protective roles in metabolic disorders, hypertension, renal injury, and neuroinflammation. Her publications in high-impact journals such as Toxicology Letters, Endocrinology, PLoS One, and Journal of Nutritional Biochemistry highlight rigorous experimental approaches and translational relevance, positioning her research as a significant reference point in toxicology, pharmacology, and metabolic disease research.

Citation Metrics (Scopus)

1600

1200

800

400

0

Citations
1,584

h-index
22

Citations

h-index


View Scopus Profile

Featured Publications

Yucheng Lu | Neuroscience | Research Excellence Award

Published on by Book of Award

Prof. Yucheng Lu | Neuroscience | Research Excellence Award

Linyi People's Hospital | China

Prof. Yucheng Lu is a distinguished researcher whose scholarly contributions span cancer biology, immunology, and translational biomedical sciences. With 352 citations, 26 indexed publications, and an h-index of 13, he has established a strong research footprint in molecular oncology and disease pathology. Over his academic career, he has published 40 peer-reviewed papers, including 25 as first or corresponding author, reflecting consistent leadership in scientific inquiry. His work encompasses cutting-edge topics such as tumor-associated macrophage regulation in glioma, prognostic biomarkers in low-grade glioma, colorectal cancer therapeutics, and single-cell transcriptomics in esophageal cancer. In addition, he has explored metabolic and immunological disease interactions, cancer proliferation mechanisms, and neural electrophysiological responses. As a principal investigator, he has led 7 provincial and municipal research projects and contributed to 8 national and ministerial-level initiatives, demonstrating strong project management and interdisciplinary collaboration. His research excellence has earned 3 Science and Technology Achievement Awards, alongside innovations represented by 1 invention patent and 6 software copyrights. Through these achievements, Prof. Lu continues to advance biomedical research with significant scientific, clinical, and technological impact.

Profile : Scopus | Orcid

Featured Publications

Shi, H., Cheng, Y., Chao, D., Song, Q., Han, L., Li, H., Lu, Y., & Wang, M. (2025). Spatiotemporal profiling of endocytic regulators in the immunosuppressive TAM microenvironment of glioma. Brain Research, 150086. (In press)

Author names not provided. (2025). Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma. Scientific Reports.

Author names not provided. (2025). Okanin suppresses the growth of colorectal cancer cells by targeting Peroxiredoxin 5. Advanced Science.

Shi, K., Li, Y., Yang, L., Zhang, Z., Guo, D., Zhang, J., & Lu, Y. (2022). Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing. The FASEB Journal, 0892-6638.

Zhao, J. Z., Lu, Y. C., Wang, Y. M., Xiao, B. L., Li, H. Y., Lee, S. C., & Wang, L. J. (2022). Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma. International Journal of Diabetes in Developing Countries, 0973-3930.

Shi, K., Zhang, J. Z., Yang, L., Li, N. N., Yue, Y., Du, X. H., Zhang, X. Z., Lu, Y. C., & Guo, D. (2021). Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer, 1471-2407.

Lu, Y., Lv, B., & Song, Q. (2019). Transcranial electrical stimulation motor-evoked potentials in a spinal cord ischaemia rabbit model. Chinese Neurosurgical Journal, 2057-4967.

Lu, Y. C., Wang, P., Wang, J., Ma, R., & Lee, S. C. (2019). PCNA and JNK1-Stat3 pathways respectively promote and inhibit diabetes-associated centrosome amplification by targeting the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells. Journal of Cellular Physiology.

Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

IRCCS Synlab SDN | Italy

Dr. Giovanni Smaldone is a highly accomplished researcher whose work spans molecular biology, structural biochemistry, oncology, immunology, and advanced diagnostic technologies. With 1,037 citations, 83 published works, and an h-index of 18, his contributions reflect both productivity and strong scientific impact. His research integrates structural biology, NMR spectroscopy, molecular interactions, and translational oncology, with a particular emphasis on childhood acute lymphoblastic leukemia (ALL). He has led and contributed to numerous funded research projects, including competitive grants focused on long non-coding RNAs, epigenetic markers, and the KCTD protein family in pediatric leukemia. His studies also extend into protein delivery systems, nanogels, cellular imaging, and biobank development for rare pediatric disorders. Dr. Smaldone’s recent publications highlight advancements in 3D refractive index tomography for leukemia cell analysis, targeted drug-delivery platforms, diagnostic biomarkers such as circular RNAs and LINC00958, and the structural mechanisms underlying KCTD–Cullin 3 interactions. His work frequently appears in high-impact journals across molecular sciences, biomedical engineering, nanotechnology, and clinical research. Additionally, he has presented widely at national and international scientific conferences, contributing to knowledge dissemination in cellular biophysics, protein structure, pediatric oncology, and advanced molecular diagnostics.

Profiles : Scopus | Orcid

Featured Publications

Bianco, V., Pirone, D., Schiavo, M., Bianco, V., Miccio, L., Memmolo, P., Smaldone, G., Pecoraro, G., Altieri, F., Salvatore, M., et al. (2026). Quantitative mapping of leukemia cells and intracellular lipid droplets using 3D refractive index tomography in flow cytometry. IEEE Journal of Selected Topics in Quantum Electronics.

Pizzella, M., Accardo, A., Mercurio, F. A., Sibillano, T., Gallo, E., Morelli, G., Smaldone, G., Giannini, C., Leone, M., Balasco, N., et al. (2025). Structural and functional characterization of self-assembling fragments identified from the transthyretin amyloid-like structure. Nanoscale.

Leone, I., Costabile, V., Smaldone, G., Franzese, M., Soricelli, A., & D’Agostino, A. (2025). Arthrospira platensis attenuates endothelial inflammation and monocyte activation. International Journal of Molecular Sciences.

Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025). Fmoc-FF nanogel-mediated delivery of doxorubicin and curcumin in thyroid cancer cells. Pharmaceutics.

Balasco, N., Esposito, L., Smaldone, G., Salvatore, M., & Vitagliano, L. (2024). A comprehensive analysis of the structural recognition between KCTD proteins and Cullin 3. International Journal of Molecular Sciences.

Bianco, V., Wang, Z., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., Mossetti, G., Maffettone, P. L., Salvatore, M., & Ferraro, P. (2024). Adaptive space-time digital holography for imaging flow cytometry and tissue slide analysis. In Digital Holography and Three-Dimensional Imaging (DH 2024).

Coppola, L., Grimaldi, A. M., Sarnacchiaro, G., Di Fasano, M. S., Smaldone, G., & Salvatore, M. (2024). An overview of Synlab SDN Biobank’s quality control system. Scientific Reports.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Biobank for craniosynostosis and faciocraniosynostosis: A study protocol. Child’s Nervous System.

Bianco, V., Valentino, M., Pirone, D., Miccio, L., Memmolo, P., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., & Mossetti, G. (2024). Classifying breast cancer and fibroadenoma tissue biopsies using fractal biomarkers in Fourier ptychographic microscopy. Computational and Structural Biotechnology Journal.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Correction: Biobank for craniosynostosis and faciocraniosynostosis. Child’s Nervous System.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Scientific Reports.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Research Square.

Filomena, A., Smaldone, G., Ginevra, S., Santiago, N., Di Fasano, M. S., Peppino, M., Alessandra, C., Antonia, D. M., Giuliana, B., Rosanna, P., et al. (2024). Identification of a circular RNA isoform of WASHC2A as a prognostic factor for high-risk pediatric B-ALL. Biomedicine & Pharmacotherapy.

Raymundo, J. R., Zhang, H., Smaldone, G., Zhu, W., Daly, K. E., Glennon, B. J., Pecoraro, G., Salvatore, M., Devine, W. A., Lo, C. W., et al. (2024). KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions. Journal of Clinical Investigation.

Altieri, F., Buono, L., Lanzilli, M., Mirabelli, P., Cianflone, A., Beneduce, G., De Matteo, A., Parasole, R., Salvatore, M., & Smaldone, G. (2024). LINC00958 as a diagnostic and prognostic biomarker of childhood B-cell acute lymphoblastic leukemia. Frontiers in Oncology.

Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mrs. Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Medical University-Plovdiv | Bulgaria

Mrs. Valentina Mihaylova is a dedicated researcher and specialist in medical chemistry with a strong focus on cellular metabolism, mitochondrial function, oxidative stress, and autoimmune diseases. With an h-index of 2, she has authored five scientific publications, which have collectively garnered 14 citations, reflecting her growing impact in medical biology and clinical research. Her work encompasses the study of markers of oxidative stress and insulin resistance in chronic autoimmune Hashimoto’s thyroiditis, cellular metabolic profiling in children with autism spectrum disorders, and the evaluation of therapeutic effects in rheumatoid arthritis through mitochondrial function and bioenergetic metabolism. Mrs. Mihaylova’s research also explores intestinal permeability, systemic inflammation, and the pharmacological effects of treatments such as methotrexate and JAK inhibitors on mitochondrial function and oxidative stress. She has actively contributed to numerous national and international conferences, presenting pioneering findings on the role of mitochondria, autophagy, and inflammation in autoimmune and rheumatologic conditions. Her academic and professional trajectory, spanning positions from clinical chemist to Master of Medical Chemistry at the Medical University of Plovdiv, is marked by a commitment to advancing knowledge in medical biology and translational research. Through her multidisciplinary approach, Mrs. Mihaylova continues to elucidate complex biochemical mechanisms underlying disease pathology and therapeutic responses, establishing herself as an emerging contributor to the field of medical and clinical biochemistry.

Profiles : Scopus | Orcid

Featured Publications

Mihaylova, V., Tomov, D., Karalilova, R., Batalov, Z., Batalov, A., Sarafian, V., & Kazakova, M. (2025). Effects of methotrexate and tofacitinib on mitochondrial function and oxidative stress in human synovial cells in vitro. International Journal of Molecular Sciences, 26(17), 8173.

Tomov, D. G., Levterova, B. A., Mihaylova, V. N., Troev, D. M., Miteva, M. Z., Uzunova, Y. I., & Orbetzova, M. M. (2024). Influence of the increase in intestinal permeability and microbiota change in the development of Hashimoto's thyroiditis: A systematic review. Endocrine and Metabolic Science, 100195.

Mihaylova, V., Kazakova, M., Batalov, Z., Karalilova, R., Batalov, A., & Sarafian, V. (2023). JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: A pilot study. Rheumatology International.

Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundation, returnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications

📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025

📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025

📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025

📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025

📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016

Kalei Hering | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Kalei Hering | Medicine and Dentistry | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Kalei Hering’s academic journey began at the United States Military Academy at West Point, where she majored in Life Sciences with honors, following a pre-medical and nuclear engineering track. As a Barry Goldwater Scholar and Rhodes Scholar Finalist, her undergraduate years were marked by distinction and ambition. She then advanced to Harvard Medical School, where she pursued her M.D. with exceptional performance, scoring a 265 on the USMLE Step 2 CK and actively engaging in research and leadership.

🩺 Professional Endeavors

Currently a Resident Physician in Diagnostic Radiology at Walter Reed National Military Medical Center (expected 2030), Dr. Hering is integrating rigorous clinical training with a robust military medical background. She has held numerous leadership positions—from Platoon Leader to President of Harvard’s Interventional Radiology Interest Group—reflecting a rare blend of military discipline and medical acumen. Her clinical and surgical experiences at institutions like Walter Reed, MGH, and BIDMC have laid a strong foundation for a future in academic and interventional radiology.

🔬 Contributions and Research Focus

Dr. Hering’s research spans vascular and interventional radiology, pulmonary arteriovenous malformations, trauma imaging, and military health, with over 20 peer-reviewed publications. She has contributed to top-tier journals including CHEST, Spine Journal, Journal of Vascular and Interventional Radiology, and Military Medicine. As an editor for the MGH “White Book”, she has also shaped essential medical manuals for house staff. Her passion for research was recognized early through internships and fellowships, including work on Lyme disease and steroid hormone physiology.

🏅 Accolades and Recognition

A decorated scholar and athlete, Dr. Hering has earned numerous honors including:
🏆 1897 Fellowship Awardee (Top national Phi Kappa Phi applicant)
🥇 Trainee Case Competition Winner, New England Society of Interventional Radiology
🏃‍♀️ Champion in multiple marathons and ultramarathons including the Candlelight 12-Hour and Spartan Race
🎖️ Excellence in Life Science Award, Brigadier General Ramsden Award, and LTC Boyd Harris Leadership Award at West Point
📚 Recognized by the West Point Superintendent for academic, military, and physical excellence

🌍 Impact and Influence

Dr. Hering is a changemaker in both academic medicine and military health systems. Her efforts to increase access and mentorship—such as developing shadowing programs, founding wellness initiatives, and mentoring underrepresented pre-med students—demonstrate her commitment to building inclusive, high-impact medical communities. Her involvement in the Society of Interventional Radiology, Excelsior Surgical Society, and Empower Conference reflects a strategic vision for the future of healthcare delivery, particularly in military and interventional contexts.

🔮 Legacy and Future Contributions

With a rare combination of military leadership, scientific rigor, and clinical excellence, Dr. Kalei Hering is poised to leave a lasting mark on the fields of interventional radiology, medical education, and military medicine. Her pursuit of innovative techniques, policy development, and mentorship ensures that her influence will be deeply felt across clinical, academic, and operational environments for years to come. As she advances through her residency and beyond, Dr. Hering stands as a beacon of resilience, intellect, and service in modern medicine.

Publications

📄 Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: CHEST

  • Year: 2025

📄 Embolization of a Bleeding Duodenal Arteriovenous Malformation with a Conformable Embolic Material (Obsidio): Case Report

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: Journal of Clinical Interventional Radiology ISVIR

  • Year: 2025

📄 Long-Term Quality of Life and Functional Outcomes After Management of Spinal Epidural Abscess

  • Authors:  Kalei Hering, Grace X. Xiong, Andrew Nguyen, Andrew J. Schoenfeld

  • Journal:  The Spine Journal

  • Year: 2024

📄 Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

  • Authors: Kalei Hering, Miles W.A. Fisher, Michael K. Dalton, Andrew K. Simpson, Jamie Ye, Nishant Suneja, Zara Cooper, Tracey P. Koehlmoos, Andrew J. Schoenfeld

  • Journal: Journal of Bone and Joint Surgery

  • Year: 2022

 

Ester Tellone | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

Published on by Book of Award

Prof. Ester Tellone | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

University of Messina | Italy

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Ester Tellone began her academic journey with a degree in Biological Sciences (1989) from the University of Messina, graduating with highest honors (110/110 cum laude). She followed this with a second degree in Natural Sciences (1996), again with top marks and a thesis on hemoglobin function in dolphins. Her early research was focused on environmental and marine biology, including dystrophic crises in lake ecosystems.

👩‍🔬 Professional Endeavors

Prof. Tellone embarked on her academic career in 1990 as a Technical Officer at the University of Messina. In 2001, she was appointed as a confirmed researcher and later became an Associate Professor in Biochemistry (BIO/10) in 2018. Since January 2022, she holds the title of Full Professor in the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences at the University of Messina. She has taught various biochemistry courses at undergraduate and postgraduate levels and has been involved in curriculum development, Ph.D. supervision, and departmental governance.

🔬 Contributions and Research Focus

Prof. Tellone's research is centered on red blood cells (erythrocytes) as model systems. Key research themes include:

🧪 Red Blood Cells: Investigating erythrocytes as biosensors and drug delivery systems and exploring amyloid protein aggregation effects.

🧬 Hemoglobin Functionality: Analyzing structural-functional properties and oxygenation dynamics in hemoglobins.

🧫 Band 3 Protein Interactions: Studying its interplay with deoxyhemoglobin and glycolytic enzymes in metabolic regulation.

Her work employs advanced mathematical models and biochemical tools to unravel complex cellular mechanisms, especially oxidative stress, apoptosis, and environmental toxicity in marine and human systems.

🏆 Accolades and Recognition

Prof. Tellone’s excellence has been widely recognized:

🥇 She holds a National Scientific Qualification for Full Professor in General Biochemistry (BIO/10).

📚 She is the author of over 80 scientific articles indexed in Scopus/Web of Science and has contributed chapters to internationally published books.

🧑‍🏫 She has served as Scientific Coordinator for several major EU- and MIUR-funded projects, including INNOVAQUA, 4FRAILTY, ORTHO Line, and SAMOTHRACE.

She is a reviewer for high-impact journals such as Molecules, Journal of Functional Foods, and British Journal of Hematology, and serves on editorial boards of multiple international scientific journals.

🌍 Impact and Influence

Prof. Tellone’s research has made significant contributions in both basic and applied science:

🔬 Her studies on red blood cells and hemoglobin have advanced understanding of diseases like ALS, Alzheimer’s, and diabetes.

🌱 Her environmental research has influenced biotechnological innovations in aquaculture, marine biology, and environmental biosensors.

👩‍🎓 As a mentor and Ph.D. supervisor, she has nurtured the careers of numerous researchers and students in the field of biochemistry.

🌟 Legacy and Future Contributions

Prof. Ester Tellone is a recognized thought leader in red blood cell biochemistry, environmental toxicology, and oxidative stress. Her work bridges molecular biology, environmental sciences, and medical biochemistry, creating interdisciplinary solutions for modern scientific challenges. With her continued involvement in international projects, editorial activities, and mentoring, her influence is set to grow further, shaping the next generation of biochemists and biomedical researchers.

Publications

📄 Exploring Tumor Cell–Platelet Biochemical Interactions by Dielectric Measurements of Blood: A Potential Target for Tumor Detection and Staging
Journal: Biology
Year: 2025 
Authors: Annamaria Russo, Ester Tellone, Francesco Farsaci

📄 Crosstalk Between Sickle Cell Disease and Ferroptosis
Journal: International Journal of Molecular Sciences
Year: 2025 
Authors: Annamaria Russo, Giuseppe Tancredi Patanè, Antonella Calderaro, Davide Barreca, Ester Tellone, Stefano Putaggio

📄 Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Journal: Molecules
Year: 2025 
Authors: Annamaria Russo, Stefano Putaggio, Ester Tellone, Antonella Calderaro, Santa Cirmi, Giuseppina Laganà, Silvana Ficarra, Davide Barreca, Giuseppe Tancredi Patanè

📄 Epicatechin Influence on Biochemical Modification of Human Erythrocyte Metabolism and Membrane Integrity
Journal: International Journal of Molecular Sciences
Year: 2024 
Authors: Annamaria Russo, Giuseppe Tancredi Patanè, Giuseppina Laganà, Santa Cirmi, Silvana Ficarra, Davide Barreca, Elena Giunta, Ester Tellone, Stefano Putaggio

📄 Canine and Human Red Blood Cells: Biochemical Mechanisms for the Control of Heat Dissipation
Journal: Stresses
Year: 2024 
Authors: Annamaria Russo, Giuseppe Tancredi Patanè, Stefano Putaggio, Ester Tellone, Silvana Ficarra, Davide Barreca, Giuseppina Laganà

Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Guangdong Provincial Laboratory of Traditional Chinese Medicine | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Li’s academic path began with an exceptional undergraduate performance in Chemistry at Jilin University. Her passion for science led her to pursue a Master’s degree in Analytical Chemistry and subsequently a Ph.D. in the same field, which she completed in July 2014 under the guidance of esteemed professor Zhang Shusheng. During her doctoral studies, she received comprehensive training in analytical techniques and developed a strong interest in practical applications related to food and environmental safety.

🏢 Professional Endeavors

In 2014, Dr. Li joined the School of Public Health at Jilin University as a faculty member. She steadily rose through the ranks to become a full professor and doctoral supervisor. Her responsibilities have included leading multiple high-level national projects, mentoring graduate students, and engaging in collaborative research across disciplines. She has become a pivotal figure in shaping the academic direction of the university’s public health research programs.

🔬 Contributions and Research Focus

Dr. Li’s research primarily focuses on food safety risk assessment, monitoring of toxic and hazardous substances in the food chain, and the development of advanced analytical methods. She has published over 80 high-impact academic papers, including articles in Analytical Chemistry, Biosensors and Bioelectronics, ACS Sensors, and TrAC Trends in Analytical Chemistry. Her work integrates innovative electrochemical and optical biosensing techniques, making significant advancements in the detection of pesticide residues, foodborne pathogens, and environmental pollutants.

🏆 Accolades and Recognition

Her excellence has not gone unnoticed. Dr. Li has received several prestigious honors, including the “Young Elite Scientists Sponsorship Program” by the China Association for Science and Technology and the First Prize for Scientific and Technological Progress by the Jilin Provincial Government. She has also served as a visiting scholar at the University of Michigan, where she broadened her international research collaboration network.

🌍 Impact and Influence

Dr. Li's research has had a profound impact on public health, food regulation, and environmental policy. Her cutting-edge methodologies contribute directly to national standards and have been implemented in real-world food safety monitoring. She is also an active member of professional organizations and frequently serves as a reviewer for top-tier scientific journals, thereby shaping the future of analytical science and public health on both national and global scales.

🔮 Legacy and Future Contributions

Looking forward, Dr. Yuanyuan Li is poised to continue her groundbreaking work in biosensor development and integrated health risk assessment. Her vision is to establish more comprehensive detection platforms that can safeguard food and environmental quality, ultimately enhancing public health resilience. As a mentor, researcher, and innovator, her legacy is one of rigorous science combined with a deep commitment to societal well-being.

 

Publications

📄 Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation

Authors:
De-Sheng Xu, Yan Wang, Zi-Rui Li, Ping-Li Mo, Ming-Tai Chen, Rui-Zhi Zhao, Zheng Fan, Wen-Jie Mo, Qi-Lu Li, Fang-Cao Pi, Qi-Di Sun, Juan-Min Li, Yun-Da Yao, Jian-Ping Chen, Yuan-Yuan Li, Jie-Nan Luan, Shang-Bin Zhang, Ying Xie, Hua Zhou

Journal: Pharmacological Research   Year: 2025

📄 Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice

Authors:
W.-T. Wang, Y.-Y. Zhang, Z.-R. Li, J.-M. Li, H.-S. Deng, Y.-Y. Li, H.-Y. Yang, C.-C. Lau, Y.-J. Yao, H.-D. Pan, L. Liu, Y. Xie, H. Zhou et al.

Journal: Phytomedicine   Year: 2024

📄 A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment

Authors:
M.-T. Chen, F.R. Huang, B.-H. Chen, J.-L. Kang, Y.-J. Yao, M.-N. Liu, Y.-Y. Li, Y.-Q. Li, T.-R. Zhou, D.-T. Peng, L.-D. Luo, C.-S. Wei, Y.-F. Xing, Q.-B. Wu, H. Zhou, G.-D. Tong

Journal: Biomedicine & Pharmacotherapy   Year: 2023

Shuai Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Shuai Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

School of Medicine,Xiamen University | China

Author Profile

Scopus

📘 Early Academic Pursuits

Mr. Shuai Wang's academic journey began with a strong foundation in Biological Sciences, earning his Bachelor’s degree from Yantai University (2014–2018). He then pursued a Master’s degree in Biology (2018–2019) and a PhD in Cell Biology (2019–2023) from Xiamen University, one of China's top research institutions. This rapid academic progression reflects his commitment to understanding complex biological systems, particularly in disease mechanisms and cellular functions.

💼 Professional Endeavors

Since September 2023, Mr. Wang has served as an Assistant Researcher at the School of Medicine, First Affiliated Hospital of Xiamen University. His work spans academic and translational research in molecular biology and metabolic disorders, with an emphasis on mechanisms of thermogenesis, obesity, and chemotherapy resistance in liver cancer. Prior to this role, he gained substantial laboratory experience during his doctoral training, shaping his precision and insight in experimental design and scientific interpretation.

🔬 Contributions and Research Focus

Mr. Wang's primary research contributions revolve around metabolic regulation, adipocyte biology, and molecular signaling pathways. He has a special interest in how transcription factors like SOX4 influence the development and function of brown and beige adipose tissue, crucial for thermogenesis and metabolic health. His recent involvement in National Natural Science Foundation-funded research explores the role of DNA demethylase TET1 in chemoresistance in liver cancer—a timely and impactful topic in cancer therapy.

🏆 Accolades and Recognition

Mr. Wang has authored several high-impact publications in prestigious journals, including:

  • Cell Death and Differentiation (2024) – as sole first author, on SOX4 and brown fat development

  • Journal of Cardiovascular Medicine and Cardiology (2024) – sole first author, linking obesity to cardiovascular diseases

  • iScience (2023) and Theranostics (2022) – as co-first author, detailing SOX4’s role in white adipose tissue and adaptive thermogenesis

  • Food Chemistry (2025) – as co-corresponding author, exploring antioxidant mechanisms via computational chemistry

These publications establish his reputation as a rising researcher with both depth and interdisciplinary reach.

🌍 Impact and Influence

Through his pioneering research in thermogenic gene regulation and molecular metabolism, Mr. Wang contributes directly to the fields of metabolic disease, obesity treatment, and precision oncology. His research not only enhances our understanding of adipocyte biology but also opens doors to innovative therapies for chronic diseases and cancer.

🧭 Legacy and Future Contributions

With a promising start as an independent researcher and a growing portfolio of impactful publications, Mr. Shuai Wang is poised to become a leading figure in biomedical research. His future work is expected to deepen the mechanistic understanding of metabolic health and cancer resistance, while inspiring collaborations across disciplines like biomedicine, pharmacology, and computational biology.

Publications

📝 Synergistic effects of polymethoxyflavonoids from citrus peel extracts on harmful compound formation and flavor quality in grilled beef patties

  • Authors: Z. Huang, Y. Xu, S. Wang, W. Quan

  • Journal: Food Chemistry

  • Year: 2025

📝 SOX4 facilitates brown fat development and maintenance through EBF2-mediated thermogenic gene program in mice

  • Authors: Shuai Wang, Ting He, Ya Luo, Kexin Ren, Huanming Shen, Lingfeng Hou, Yixin Wei, Tong Fu, Wenlong Xie, Peng Wang, Jie Hu, Yu Zhu, Zhengrong Huang, Qiyuan Li, Weihua Li, Huiling Guo, Boan Li

  • Journal: Cell Death and Differentiation

  • Year: 2024

📝 Obesity: A Key Causative Factor in Cardiovascular Disease Development

  • Authors: Shuai Wang, Ting He, Chunli Mo, Kangfeng Lin, Cui Yang, Weihua Li

  • Journal: Journal of Cardiovascular Medicine and Cardiology

  • Year: 2024

📝 Suppression of preadipocyte determination by SOX4 limits white adipocyte hyperplasia in obesity

  • Authors: Ting He, Shuai Wang, Shengnan Li, Huanming Shen, Lingfeng Hou, Yunjia Liu, Yixin Wei, Fuan Xie, Zhiming Zhang, Zehang Zhao, Chunli Mo, Huiling Guo, Qingsong Huang, Rui Zhang, Dongyan Shen, Boan Li

  • Journal: iScience

  • Year: 2023

📝 SOX4 promotes beige adipocyte-mediated adaptive thermogenesis by facilitating PRDM16-PPARγ complex

  • Authors: Huanming Shen, Ting He, Shuai Wang, Lingfeng Hou, Yixin Wei, Yunjia Liu, Chunli Mo, Zehang Zhao, Weixin You, Huiling Guo, Boan Li

  • Journal: Theranostics

  • Year: 2022

📝 Augmenting antioxidative capacity of myosin and cytoprotective potential of myosin digestion products through the integration of crocin and crocetin: A comprehensive analysis via quantum chemical computing and molecular dynamics

  • Authors: Chaoyi Xue, Jian Zhang, Chenxia Zhang, Zhonghao Hu, Huixue Liu, Lan Mo, Maiquan Li, Aihua Lou, Qingwu Shen, Jie Luo, Shuai Wang, Wei Quan

  • Journal: Food Chemistry

  • Year: 2025